U.S. in Pact with Pfizer (PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
EPS Growth %: -12.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
EPS Growth %: -12.8%
Join SI Premium – FREE
U.S. in Pact with Pfizer (NYSE: PFE) for 100 Million Covid-19 Vaccine Doses - Bloomberg
Related: BioNTech SE (NASDAQ: BNTX)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Robinhood prices $2B convertible notes offering due 2029
- Moderna Wins Fda Panel Backing For Mrna Flu Vaccine
Create E-mail Alert Related Categories
Corporate News, FDA, Hot FDA NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
